# HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/her2-genomic-amplification-in-circulating-tumor-dna-from-patients-with-cetuximab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Naoki Takegawa,Kimio Yonesaka,Kazuko Sakai,Hiroto Ueda,Satomi Watanabe,Yoshikane Nonagase,Tatsuya Okuno,Masayuki Takeda,Osamu Maenishi,Junji Tsurutani,Taroh Satoh,Isamu Okamoto,Kazuto Nishio,Takao Tamura,Kazuhiko Nakagawa |
| Citations | 70 |
| DOI | 10.18632/oncotarget.6498 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.oncotarget.com/article/6498/pdf/ |
| OpenAlex ID | https://openalex.org/W2220166442 |
| PMID | 26657506 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Satomi Watanabe](https://scholariq.org/researchers/satomi-watanabe/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.